Undisclosed Oncolytic Virus Program

About Stratosvir

Stratosvir is an early-stage biotech leveraging engineered oncolytic viruses to treat solid tumors, with a specific platform aimed at overcoming the critical barrier of systemic delivery. The company has attracted investment from cancer-focused organizations like Proven Connect (Prostate Cancer Research) and received an Innovate UK R&D grant, indicating external validation. Led by a seasoned team with deep experience in virology, biotech, and oncology deal-making, Stratosvir is positioned to advance its platform from pre-clinical development towards clinical testing.

Therapeutic Areas